Exploring Substance Use Disorders and Treatment Strategies

This chapter delves into the challenges of addressing substance use disorders, highlighting responsible prescribing, the rise of synthetic substances, and the need to combat stigma for effective treatment. It discusses medications like naltrexone and buprenorphine for alcohol and opioid use, emphasizing an integrated approach for better patient engagement. Additionally, it touches on the effectiveness of a monoclonal antibody, Nercivamob, in reducing hospitalizations due to RSV in infants, and covers various medical topics like gastroesophageal reflux disease and esophageal cancer.